Mirtazapine (Page 10 of 10)

Mirtazapine 15 mg x 100 Tablets — Label

NDC 0185-0020-01

Mirtazapine Tablets, USP

15 mg

PHARMACIST: Please dispense with Medication Guide provided separately..

Rx only

100 Tablets

Sandoz

15 mg x 100 Tablets
(click image for full-size original)

Mirtazapine 30 mg x 100 Tablets — Label

NDC 0185-0212-01

Mirtazapine Tablets, USP

30 mg

PHARMACIST: Please dispense with Medication Guide provided separately.

Rx only

100 Tablets

Sandoz

30 mg x 100 Tablets
(click image for full-size original)

Mirtazapine 45 mg x 100 Tablets — Label

NDC 0185-0222-01

Mirtazapine Tablets, USP

45 mg

PHARMACIST: Please dispense with Medication Guide provided separately.

Rx only

100 Tablets

Sandoz

45 mg x 100 Tablets
(click image for full-size original)
MIRTAZAPINE
mirtazapine tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0185-0020
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MIRTAZAPINE (MIRTAZAPINE) MIRTAZAPINE 15 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
HYPROMELLOSES
FERRIC OXIDE YELLOW
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
POLYETHYLENE GLYCOLS
POLYSORBATE 80
STARCH, CORN
TITANIUM DIOXIDE
Product Characteristics
Color YELLOW Score 2 pieces
Shape ROUND Size 7mm
Flavor Imprint Code E;20
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0185-0020-30 30 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:0185-0020-01 100 TABLET, FILM COATED in 1 BOTTLE None
3 NDC:0185-0020-05 500 TABLET, FILM COATED in 1 BOTTLE None
4 NDC:0185-0020-10 1000 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076219 06/19/2003
MIRTAZAPINE
mirtazapine tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0185-0212
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MIRTAZAPINE (MIRTAZAPINE) MIRTAZAPINE 30 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
FD&C YELLOW NO. 6
HYPROMELLOSES
FERRIC OXIDE RED
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
POLYETHYLENE GLYCOLS
POLYSORBATE 80
STARCH, CORN
TITANIUM DIOXIDE
Product Characteristics
Color BROWN (red-brown) , RED (red-brown) Score 2 pieces
Shape ROUND Size 9mm
Flavor Imprint Code E;212
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0185-0212-10 1000 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:0185-0212-05 500 TABLET, FILM COATED in 1 BOTTLE None
3 NDC:0185-0212-01 100 TABLET, FILM COATED in 1 BOTTLE None
4 NDC:0185-0212-30 30 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076219 06/19/2003
MIRTAZAPINE
mirtazapine tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0185-0222
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MIRTAZAPINE (MIRTAZAPINE) MIRTAZAPINE 45 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
HYPROMELLOSES
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
POLYETHYLENE GLYCOLS
POLYSORBATE 80
STARCH, CORN
TITANIUM DIOXIDE
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 10mm
Flavor Imprint Code E;222
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0185-0222-30 30 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:0185-0222-01 100 TABLET, FILM COATED in 1 BOTTLE None
3 NDC:0185-0222-05 500 TABLET, FILM COATED in 1 BOTTLE None
4 NDC:0185-0222-10 1000 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076219 06/19/2003
Labeler — Eon Labs, Inc. (012656273)

Revised: 03/2016 Eon Labs, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.